Email ID
Password
Scrip   
EU's CHMP recommends Bial's anti-epileptic Zebinix
20 February 2009
Katie McQue

The EU's CHMP has recommended that a marketing authorisation be granted to Bial's Zebinix (eslicarbazepine acetate) for adjunctive therapy in adults with partial-onset seizures with or without secondary generalisation. Zebinix will be available in 400mg, 600mg and 800mg tablets.

Bial...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36